Summary:
– Researchers at the Fraunhofer Translational Center for Regenerative Therapies have created a fully-automated bioreactor for cultivating human-induced pluripotent stem cells (hiPSCs) long-term.
– This new bioreactor system can support the culture of hiPSCs for up to three months, providing a controlled environment for their growth.
Author’s Take:
The development of a fully-automated bioreactor by researchers at the Fraunhofer Translational Center for Regenerative Therapies marks a significant advancement in the field of stem cell culture. With the ability to support hiPSCs for up to three months, this innovative technology opens up new possibilities for long-term cell culture and regenerative therapies.
Click here for the original article.